Rajput et al found that TLR4 activation promotes carcinogenesis and resistance to chemical treatments in breast cancer [13], [14], whereas blocking TLR4 activation can slow breast cancer growth and prolong survival [20]. This evidence concerns the gene TLR4 and breast cancer.